SCHEMBL26645286

SCHEMBL26645286

CC1c2c(-c3ccncc3)c(-c3ccc(Cl)cc3F)nn2CCN1C(=O)/C=C/CN(C)C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 7/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ FRK P42685 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ CSNK1A1 P48729 1/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ MINK1 Q8N4C8 1/20 0.38
▸ BCHE P06276 1/20 0.35
▸ BTK Q06187 5/20 0.35
▸ MAPK11 Q15759 3/20 0.34
▸ MAPK14 Q16539 3/20 0.34
▸ KRAS P01116 2/20 0.34
▸ ERBB2 P04626 1/20 0.33
▸ ENPP2 Q13822 3/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33
▸ FGFR1 P11362 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30622301 1.00 EGFR (0.38) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL30622336 1.00 EGFR (0.38) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL30622374 0.86 BCHE (0.39) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL26645237 0.86 BCHE (0.39) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL26644950 0.85 KRAS (0.35) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL30622327 0.85 KRAS (0.35) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL26645397 0.84 BCHE (0.41) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL26645712 0.83 EGFR (0.37) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL30622978 0.79 CYP3A4 (0.39) EGFRMAP4K4PRKACAFRKMAPK9
SCHEMBL26644815 0.79 BTK (0.39) EGFRMAP4K4PRKACAFRKMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback